Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membrane ecto-ATPase on epidermal Langerhans cells.

G Girolomoni1, M L Santantonio, P R Bergstresser

  • 1Department of Dermatology, University of Modena, Italy.

The Journal of Investigative Dermatology
|November 11, 1992
PubMed
Summary

Epidermal Langerhans cells (LC) resist extracellular ATP (ATPo) effects due to their ecto-ATPase. This enzyme may protect LCs from ATP-induced cell death, a mechanism potentially active in vivo.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of psoriasis following initiation of biologic therapy is associated with lower risk of developing psoriatic arthritis: A single-center, retrospective, cohort study.

Journal of the American Academy of Dermatology·2025
Same author

European Guideline (EuroGuiDerm) on atopic eczema: Living update.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis).

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.

Expert opinion on biological therapy·2023

Area of Science:

  • Immunology
  • Cell Biology
  • Dermatology

Background:

  • Epidermal Langerhans cells (LC) have a Mg(++)- or Ca(++)-dependent ecto-ATPase (mATPase) with unknown function.
  • Extracellular ATP (ATPo) increases cell membrane permeability, facilitating entry of substances and potentially causing cell death.
  • ATPo is also implicated as a mediator in T cell-mediated cytotoxicity.

Purpose of the Study:

  • To investigate the role of mATPase in human LC.
  • To compare the susceptibility of human LC to ATPo with other cell types.
  • To explore the protective function of mATPase against ATPo-induced cell death.

Main Methods:

  • Comparative analysis of human LC, keratinocytes, and J774 macrophages.
  • In vitro experiments assessing cell membrane permeability and cell death.

Related Experiment Videos

  • Enzyme activity assays for mATPase.

    • Main Results:

    • Human LC demonstrated resistance to the permeabilizing effects of ATPo compared to keratinocytes and J774 macrophages.
    • Preliminary in vitro evidence suggests mATPase on LC confers protection against ATPo-induced lysis.
    • LCs exhibit unique resistance mechanisms to extracellular ATP.

    Conclusions:

    • Human epidermal Langerhans cells possess a protective mATPase against extracellular ATP.
    • This ecto-ATPase may play a crucial role in LC survival and function in vivo.
    • Further research is warranted to elucidate the in vivo implications of this protective mechanism.